These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1301 related articles for article (PubMed ID: 17631342)
1. Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era. Boorjian SA; Thompson RH; Siddiqui S; Bagniewski S; Bergstralh EJ; Karnes RJ; Frank I; Blute ML J Urol; 2007 Sep; 178(3 Pt 1):864-70; discussion 870-1. PubMed ID: 17631342 [TBL] [Abstract][Full Text] [Related]
2. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era. DiMarco DS; Zincke H; Sebo TJ; Slezak J; Bergstralh EJ; Blute ML J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719 [TBL] [Abstract][Full Text] [Related]
3. Disease progression and survival in patients with prostate carcinoma and positive lymph nodes after radical retropubic prostatectomy. Kroepfl D; Loewen H; Roggenbuck U; Musch M; Klevecka V BJU Int; 2006 May; 97(5):985-91. PubMed ID: 16643480 [TBL] [Abstract][Full Text] [Related]
4. Long-term hazard of progression after radical prostatectomy for clinically localized prostate cancer: continued risk of biochemical failure after 5 years. Amling CL; Blute ML; Bergstralh EJ; Seay TM; Slezak J; Zincke H J Urol; 2000 Jul; 164(1):101-5. PubMed ID: 10840432 [TBL] [Abstract][Full Text] [Related]
5. Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy. Eggener SE; Roehl KA; Smith ND; Antenor JA; Han M; Catalona WJ J Urol; 2005 Apr; 173(4):1150-5. PubMed ID: 15758725 [TBL] [Abstract][Full Text] [Related]
6. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. Swindle P; Eastham JA; Ohori M; Kattan MW; Wheeler T; Maru N; Slawin K; Scardino PT J Urol; 2005 Sep; 174(3):903-7. PubMed ID: 16093984 [TBL] [Abstract][Full Text] [Related]
7. Correlation of clinical and pathologic factors with rising prostate-specific antigen profiles after radical prostatectomy alone for clinically localized prostate cancer. Kupelian P; Katcher J; Levin H; Zippe C; Klein E Urology; 1996 Aug; 48(2):249-60. PubMed ID: 8753737 [TBL] [Abstract][Full Text] [Related]
8. Radical prostatectomy for pathological Gleason 8 or greater prostate cancer: influence of concomitant pathological variables. Lau WK; Bergstralh EJ; Blute ML; Slezak JM; Zincke H J Urol; 2002 Jan; 167(1):117-22. PubMed ID: 11743287 [TBL] [Abstract][Full Text] [Related]
9. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy. Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707 [TBL] [Abstract][Full Text] [Related]
10. Isolated local recurrence is rare after radical prostatectomy in men with Gleason 7 prostate cancer and positive surgical margins: therapeutic implications. Han M; Pound CR; Potter SR; Partin AW; Epstein JI; Walsh PC J Urol; 2001 Mar; 165(3):864-6. PubMed ID: 11176487 [TBL] [Abstract][Full Text] [Related]
11. Impact of prostate-specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8-10 cancers. Boorjian SA; Karnes RJ; Rangel LJ; Bergstralh EJ; Frank I; Blute ML BJU Int; 2008 Feb; 101(3):299-304. PubMed ID: 17922854 [TBL] [Abstract][Full Text] [Related]
12. The impact of positive surgical margins on mortality following radical prostatectomy during the prostate specific antigen era. Boorjian SA; Karnes RJ; Crispen PL; Carlson RE; Rangel LJ; Bergstralh EJ; Blute ML J Urol; 2010 Mar; 183(3):1003-9. PubMed ID: 20092854 [TBL] [Abstract][Full Text] [Related]
13. Radical prostatectomy improves progression-free and cancer-specific survival in men with lymph node positive prostate cancer in the prostate-specific antigen era: a confirmatory study. Steuber T; Budäus L; Walz J; Zorn KC; Schlomm T; Chun F; Ahyai S; Fisch M; Sauter G; Huland H; Graefen M; Haese A BJU Int; 2011 Jun; 107(11):1755-61. PubMed ID: 20942833 [TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of patients with prostate cancer and nodal metastases treated by pelvic lymphadenectomy and radical prostatectomy: the positive impact of adjuvant radiotherapy. Da Pozzo LF; Cozzarini C; Briganti A; Suardi N; Salonia A; Bertini R; Gallina A; Bianchi M; Fantini GV; Bolognesi A; Fazio F; Montorsi F; Rigatti P Eur Urol; 2009 May; 55(5):1003-11. PubMed ID: 19211184 [TBL] [Abstract][Full Text] [Related]
15. Anatomic site-specific positive margins in organ-confined prostate cancer and its impact on outcome after radical prostatectomy. Blute ML; Bostwick DG; Bergstralh EJ; Slezak JM; Martin SK; Amling CL; Zincke H Urology; 1997 Nov; 50(5):733-9. PubMed ID: 9372884 [TBL] [Abstract][Full Text] [Related]
16. Androgen receptor expression in prostate cancer lymph node metastases is predictive of outcome after surgery. Sweat SD; Pacelli A; Bergstralh EJ; Slezak JM; Cheng L; Bostwick DG J Urol; 1999 Apr; 161(4):1233-7. PubMed ID: 10081876 [TBL] [Abstract][Full Text] [Related]
17. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. Roehl KA; Han M; Ramos CG; Antenor JA; Catalona WJ J Urol; 2004 Sep; 172(3):910-4. PubMed ID: 15310996 [TBL] [Abstract][Full Text] [Related]
18. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. Ward JF; Slezak JM; Blute ML; Bergstralh EJ; Zincke H BJU Int; 2005 Apr; 95(6):751-6. PubMed ID: 15794776 [TBL] [Abstract][Full Text] [Related]
19. Role of early adjuvant hormonal therapy after radical prostatectomy for prostate cancer. Zincke H; Lau W; Bergstralh E; Blute ML J Urol; 2001 Dec; 166(6):2208-15. PubMed ID: 11696737 [TBL] [Abstract][Full Text] [Related]
20. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure? Bader P; Burkhard FC; Markwalder R; Studer UE J Urol; 2003 Mar; 169(3):849-54. PubMed ID: 12576797 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]